Clinical Trial Update: BOW015 (Infliximab-EPIRUS) and Infliximab in Patients With Active Rheumatoid Arthritis: The UNIFORM Study [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial comparing BOW015 (Infliximab-EPIRUS) with infliximab in patients with active rheumatoid arthritis under the UNIFOR…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BOW015 (Infliximab-EPIRUS) (Infliximab-EPIRUS)
• Infliximab (infliximab)

Snippet

Sponsor: Epirus Biopharmaceuticals (Switzerland) GmbH | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN